Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Modified 5 Factor Frailty Index is Associated With Worse PROMs and Decreased Return to Activities After 1 or 2 Level MI-TLIF.
Subramanian T, Shahi P, Hirase T, Korsun M, Zhang J, Kim E, Kwas C, Kaidi AC, Boddapati V, Song J, Asada T, Mai E, Simon C, Araghi K, Amen TB, Vaishnav A, Tuma O, Zhao E, Singh N, Allen M, Bay A, Sheha E, Lovecchio FC, Dowdell JE, Qureshi SA, Iyer S. Subramanian T, et al. Among authors: iyer s. Global Spine J. 2025 Jan 25:21925682251314380. doi: 10.1177/21925682251314380. Online ahead of print. Global Spine J. 2025. PMID: 39862223 Free PMC article.
Centriolar cap proteins CP110 and CPAP control slow elongation of microtubule plus ends.
Iyer SS, Chen F, Ogunmolu FE, Moradi S, Volkov VA, van Grinsven EJ, van Hoorn C, Wu J, Andrea N, Hua S, Jiang K, Vakonakis I, Potočnjak M, Herzog F, Gigant B, Gudimchuk N, Stecker KE, Dogterom M, Steinmetz MO, Akhmanova A. Iyer SS, et al. J Cell Biol. 2025 Mar 3;224(3):e202406061. doi: 10.1083/jcb.202406061. Epub 2025 Jan 23. J Cell Biol. 2025. PMID: 39847124 Free PMC article.
Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma.
Gaulin C, Jain P, Nair R, Iyer SP, Lee HJ, Fayad L, Feng L, Ok CY, Kanagal-Shamanna R, Oriabure O, Chen W, Xu G, Deswal A, Iliescu C, Badillo M, Ky M, Avellaneda M, Tangc G, Medeiros LJ, Vega F, Flowers CR, Wang ML. Gaulin C, et al. Among authors: iyer sp. Leuk Lymphoma. 2025 Jan 21:1-5. doi: 10.1080/10428194.2025.2454540. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39838574 No abstract available.
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB.
Torres-Cabala CA, Yescas J, Zhang Y, Huen A, Gaur S, Tefft K, Tang G, Curry JL, Gunther JR, Dabaja BS, Iyer SP, Miranda RN, Choi J, Nardi V. Torres-Cabala CA, et al. Among authors: iyer sp. Blood Adv. 2025 Jan 18:bloodadvances.2024014928. doi: 10.1182/bloodadvances.2024014928. Online ahead of print. Blood Adv. 2025. PMID: 39825823 No abstract available.
2,555 results